AVBP Revenue Flow
A current filed revenue breakdown could not be established from the retained filing evidence.
- 2026-06-30: Research and development $42.34M; Operating expenses $52.69M; Net income -$49.89M.
- 2026-03-31: Research and development $37.62M; Operating expenses $46.11M; Net income -$43.32M.
- 2025-12-31: Research and development $32.17M*; Operating expenses $38.82M*; Net income -$35.54M*.
- 2025-09-30: Research and development $32.17M; Operating expenses $38.32M; Net income -$34.98M.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Research and development | Operating expenses | Net income |
|---|
| 2026-06-30 | $42.34M | $52.69M | -$49.89M |
|---|
| 2026-03-31 | $37.62M | $46.11M | -$43.32M |
|---|
| 2025-12-31 | $32.17M* | $38.82M* | -$35.54M* |
|---|
| 2025-09-30 | $32.17M | $38.32M | -$34.98M |
|---|
| 2025-06-30 | $27.72M | $33.62M | -$31.40M |
|---|
| 2025-03-31 | $61.29M | $66.77M | -$64.39M |
|---|
| 2024-09-30 | $20.09M | $24.23M | -$20.56M |
|---|
| 2024-06-30 | $21.78M | $25.70M | -$21.87M |
|---|
| 2024-03-31 | $16.98M | $20.67M | -$17.42M |
|---|
| 2023-09-30 | $14.28M | $16.72M | -$14.40M |
|---|
| 2023-06-30 | $20.36M | $22.58M | -$21.57M |
|---|
| 2023-03-31 | $10.24M | $12.17M | -$12.17M |
|---|
Revenue and expense 6 month
| Period end | Research and development | Operating expenses | Net income |
|---|
| 2026-06-30 | $79.96M | $98.80M | -$93.21M |
|---|
| 2025-06-30 | $89.01M | $100.39M | -$95.79M |
|---|
| 2024-06-30 | $38.75M | $46.37M | -$39.29M |
|---|
| 2023-06-30 | $30.59M | $34.76M | -$33.74M |
|---|
Revenue and expense 9 month
| Period end | Research and development | Operating expenses | Net income |
|---|
| 2025-09-30 | $121.18M | $138.71M | -$130.76M |
|---|
| 2024-09-30 | $58.84M | $70.60M | -$59.85M |
|---|
| 2023-09-30 | $44.87M | $51.47M | -$48.14M |
|---|
Revenue and expense 12 month
| Period end | Research and development | Operating expenses | Net income |
|---|
| 2025-12-31 | $153.35M | $177.53M | -$166.31M |
|---|
| 2024-12-31 | $79.00M | $94.31M | -$80.49M |
|---|
| 2023-12-31 | $64.88M | $74.59M | -$69.33M |
|---|